242 related articles for article (PubMed ID: 21044962)
1. SLUG-induced elevation of D1 cyclin in breast cancer cells through the inhibition of its ubiquitination.
Mittal MK; Singh K; Misra S; Chaudhuri G
J Biol Chem; 2011 Jan; 286(1):469-79. PubMed ID: 21044962
[TBL] [Abstract][Full Text] [Related]
2. High motility of triple-negative breast cancer cells is due to repression of plakoglobin gene by metastasis modulator protein SLUG.
Bailey CK; Mittal MK; Misra S; Chaudhuri G
J Biol Chem; 2012 Jun; 287(23):19472-86. PubMed ID: 22496452
[TBL] [Abstract][Full Text] [Related]
3. TMPRSS4 induces invasion and proliferation of prostate cancer cells through induction of Slug and cyclin D1.
Lee Y; Ko D; Min HJ; Kim SB; Ahn HM; Lee Y; Kim S
Oncotarget; 2016 Aug; 7(31):50315-50332. PubMed ID: 27385093
[TBL] [Abstract][Full Text] [Related]
4. In vivo binding to and functional repression of the VDR gene promoter by SLUG in human breast cells.
Mittal MK; Myers JN; Misra S; Bailey CK; Chaudhuri G
Biochem Biophys Res Commun; 2008 Jul; 372(1):30-4. PubMed ID: 18485278
[TBL] [Abstract][Full Text] [Related]
5. Decreased BRCA1 confers tamoxifen resistance in breast cancer cells by altering estrogen receptor-coregulator interactions.
Wen J; Li R; Lu Y; Shupnik MA
Oncogene; 2009 Jan; 28(4):575-86. PubMed ID: 18997820
[TBL] [Abstract][Full Text] [Related]
6. Slug inhibits proliferation of human prostate cancer cells via downregulation of cyclin D1 expression.
Liu J; Uygur B; Zhang Z; Shao L; Romero D; Vary C; Ding Q; Wu WS
Prostate; 2010 Dec; 70(16):1768-77. PubMed ID: 20564361
[TBL] [Abstract][Full Text] [Related]
7. Cyclin D1 is necessary for tamoxifen-induced cell cycle progression in human breast cancer cells.
Kilker RL; Planas-Silva MD
Cancer Res; 2006 Dec; 66(23):11478-84. PubMed ID: 17145896
[TBL] [Abstract][Full Text] [Related]
8. Slug regulates Cyclin D1 expression by ubiquitin-proteasome pathway in prostate cancer cells.
Ding GX; Liu J; Feng CC; Jiang HW; Xu JF; Ding Q
Panminerva Med; 2012 Sep; 54(3):219-23. PubMed ID: 22801439
[TBL] [Abstract][Full Text] [Related]
9. LncRNA DILA1 inhibits Cyclin D1 degradation and contributes to tamoxifen resistance in breast cancer.
Shi Q; Li Y; Li S; Jin L; Lai H; Wu Y; Cai Z; Zhu M; Li Q; Li Y; Wang J; Liu Y; Wu Z; Song E; Liu Q
Nat Commun; 2020 Nov; 11(1):5513. PubMed ID: 33139730
[TBL] [Abstract][Full Text] [Related]
10. Curcumin suppresses 4-hydroxytamoxifen resistance in breast cancer cells by targeting SLUG/Hexokinase 2 pathway.
Geng C; Li J; Ding F; Wu G; Yang Q; Sun Y; Zhang Z; Dong T; Tian X
Biochem Biophys Res Commun; 2016 Apr; 473(1):147-153. PubMed ID: 27012210
[TBL] [Abstract][Full Text] [Related]
11. The ERα-miR-575-p27 feedback loop regulates tamoxifen sensitivity in ER-positive Breast Cancer.
Liu SS; Li Y; Zhang H; Zhang D; Zhang XB; Wang X; Yu Y
Theranostics; 2020; 10(23):10729-10742. PubMed ID: 32929377
[No Abstract] [Full Text] [Related]
12. SNAIL is induced by tamoxifen and leads to growth inhibition in invasive lobular breast carcinoma.
Bossart EA; Tasdemir N; Sikora MJ; Bahreini A; Levine KM; Chen J; Basudan A; Jacobsen BM; Burns TF; Oesterreich S
Breast Cancer Res Treat; 2019 Jun; 175(2):327-337. PubMed ID: 30798422
[TBL] [Abstract][Full Text] [Related]
13. Anterior gradient-2 plays a critical role in breast cancer cell growth and survival by modulating cyclin D1, estrogen receptor-alpha and survivin.
Vanderlaag KE; Hudak S; Bald L; Fayadat-Dilman L; Sathe M; Grein J; Janatpour MJ
Breast Cancer Res; 2010; 12(3):R32. PubMed ID: 20525379
[TBL] [Abstract][Full Text] [Related]
14. Signal transducer and activator of transcription 5b, c-Src, and epidermal growth factor receptor signaling play integral roles in estrogen-stimulated proliferation of estrogen receptor-positive breast cancer cells.
Fox EM; Bernaciak TM; Wen J; Weaver AM; Shupnik MA; Silva CM
Mol Endocrinol; 2008 Aug; 22(8):1781-96. PubMed ID: 18550772
[TBL] [Abstract][Full Text] [Related]
15. Regulation of BRCA2 gene expression by the SLUG repressor protein in human breast cells.
Tripathi MK; Misra S; Khedkar SV; Hamilton N; Irvin-Wilson C; Sharan C; Sealy L; Chaudhuri G
J Biol Chem; 2005 Apr; 280(17):17163-71. PubMed ID: 15734731
[TBL] [Abstract][Full Text] [Related]
16. AIB1 sequestration by androgen receptor inhibits estrogen-dependent cyclin D1 expression in breast cancer cells.
De Amicis F; Chiodo C; Morelli C; Casaburi I; Marsico S; Bruno R; Sisci D; Andò S; Lanzino M
BMC Cancer; 2019 Nov; 19(1):1038. PubMed ID: 31684907
[TBL] [Abstract][Full Text] [Related]
17. Estrogen regulation of cyclin E2 requires cyclin D1 but not c-Myc.
Caldon CE; Sergio CM; Schütte J; Boersma MN; Sutherland RL; Carroll JS; Musgrove EA
Mol Cell Biol; 2009 Sep; 29(17):4623-39. PubMed ID: 19564413
[TBL] [Abstract][Full Text] [Related]
18. Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner.
Shao S; Zhao X; Zhang X; Luo M; Zuo X; Huang S; Wang Y; Gu S; Zhao X
Mol Cancer; 2015 Feb; 14(1):28. PubMed ID: 25645291
[TBL] [Abstract][Full Text] [Related]
19. Convergence of oncogenic and hormone receptor pathways promotes metastatic phenotypes.
Augello MA; Burd CJ; Birbe R; McNair C; Ertel A; Magee MS; Frigo DE; Wilder-Romans K; Shilkrut M; Han S; Jernigan DL; Dean JL; Fatatis A; McDonnell DP; Visakorpi T; Feng FY; Knudsen KE
J Clin Invest; 2013 Jan; 123(1):493-508. PubMed ID: 23257359
[TBL] [Abstract][Full Text] [Related]
20. Tamoxifen stimulates the growth of cyclin D1-overexpressing breast cancer cells by promoting the activation of signal transducer and activator of transcription 3.
Ishii Y; Waxman S; Germain D
Cancer Res; 2008 Feb; 68(3):852-60. PubMed ID: 18245487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]